Search Within

Stephen D Nimer

  1. "Jing Qin"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (13)
  2. Hematologic Malignancies, Division of (13)
  3. Center for Hematologic Malignancies (10)
  4. Lymphoma (8)
  5. Radiation Oncology, Department of (8)
  6. Survivorship Research (8)

More Groups

People
  1. Jing Qin (13)
  2. Tarun Kewalramani (10)
  3. Andrew Zelenetz (8)
  4. Craig Moskowitz (8)
  5. Joachim Yahalom (8)
  6. Daniel Filippa (6)

More People

Years
  1. 2005 (1)
  2. 2004 (2)
  3. 2003 (3)
  4. 2002 (3)
  5. 2001 (3)
  6. 2000 (1)
Publications
  1. Blood (9)
  2. Bone Marrow Transplantation (2)
  3. Human Pathology (1)
  4. Modern Pathology (1)
Publishers
  1. American Society of Hematology (9)
  2. Nature Publishing Group (2)
  3. Elsevier Inc. (1)
  4. Nature Research (1)

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: Report of a phase II trial
    Journal Article

    Gupta, S.; Zhou, P.; Hassoun, H.; Kewalramani, T.; Reich, L.; Costello, S.; Drake, L.; Klimek, V.; Dhodapkar, M.; Teruya-Feldstein, J.; more...
    Bone Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Serum IL-12 : IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Tuma, R. A.; Almyroudis, N. G.; Sohn, S.; Rice, R. D.; Galinkin, D.; Blain, M.; Qin, J.; Pamer, E. G.; Nimer, S. D.
    Blood (2004)

    Fulltext@MSK | Save
  • Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • A phase II study of stem cell mobilization with IV melphalan (60 mg/M-2) + G-CSF in multiple myeloma
    Meeting Abstract

    Gupta, S.; Costello, S.; Zhou, P.; Reich, L.; Hassoun, H.; Klimek, V.; Kewalramani, T.; Dhodapkar, M.; Fleisher, M.; Hedvat, C.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma
    Journal Article

    Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Moskowitz, C. H.
    Bone Marrow Transplantation (2003)

    Fulltext@MSK | Save
  • Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma
    Journal Article

    Hamlin, P. A.; Zelenetz, A. D.; Kewalramani, T.; Qin, J.; Satagopan, J. M.; Verbel, D.; Noy, A.; Portlock, C. S.; Straus, D. J.; Yahalom, J.; more...
    Blood (2003)

    Fulltext@MSK | Save
  • Similar outcomes for chemosensitive (CS) relapsed or primary refractory peripheral T-cell lymphoma (PTCL) and diffuse large B-cell lymphoma (DLBCL) treated with autologous transplantation (ASCT)
    Meeting Abstract

    Kewalramani, T.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S.; Qin, J.; Malhotra, S.; Yahalom, J.; Moskowitz, C. H.
    Blood (2002)

    Fulltext@MSK | Save
  • Autologous transplantation (ASCT) with total body irradiation (TBI) based conditioning appears superior to chemotherapy only (Non-TBI) conditioning for patients with relapsed or primary refractory chemosensitive (CS) diffuse large B-cell lymphoma (DLBCL) who have no extranodal sits (ENS) of disease (dz)
    Meeting Abstract

    Kewalramani, T.; Moskowitz, C. H.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Nimer, S. D.
    Blood (2002)

    Fulltext@MSK | Save
  • Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma
    Journal Article

    Hedvat, C. V.; Hegde, A.; Chaganti, R. S. K.; Chen, B. Y.; Qin, J.; Filippa, D. A.; Nimer, S. D.; Teruya-Feldstein, J.
    Human Pathology (2002)

    Fulltext@MSK | Save
  • Rituximab significantly increases the complete response rate in patients with relapsed or primary refractory DLBCL receiving ICE as second-line therapy (SLT)
    Meeting Abstract

    Kewalramani, T.; Zelenetz, A.; Bertino, J.; Donnelly, G.; Hedrick, E.; Noy, A.; O'connor, O.; Portlock, C.; Straus, D.; Yahalom, J.; more...
    Blood (2001)

    Fulltext@MSK | Save